Literature DB >> 11756581

Head and neck cancer.

A Forastiere1, W Koch, A Trotti, D Sidransky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756581     DOI: 10.1056/NEJMra001375

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  364 in total

1.  A knowledge framework for computational molecular-disease relationships in cancer.

Authors:  Michael N Cantor; Yves A Lussier
Journal:  Proc AMIA Symp       Date:  2002

2.  Poly-L-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatment.

Authors:  Hyun-Jong Cho; Saeho Chong; Suk-Jae Chung; Chang-Koo Shim; Dae-Duk Kim
Journal:  Pharm Res       Date:  2011-12-15       Impact factor: 4.200

Review 3.  The biology of head and neck cancer stem cells.

Authors:  Zhaocheng Zhang; Manoel Sant'Ana Filho; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

4.  Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras.

Authors:  Sergio Acin; Zhongyou Li; Olga Mejia; Dennis R Roop; Adel K El-Naggar; Carlos Caulin
Journal:  J Pathol       Date:  2011-09-26       Impact factor: 7.996

5.  Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.

Authors:  Nabil F Saba; Xu Wang; Susan Müller; Mourad Tighiouart; Kwangjae Cho; Shuming Nie; Zhuo Chen; Dong M Shin
Journal:  Head Neck       Date:  2009-04       Impact factor: 3.147

6.  Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.

Authors:  Wanglong Qiu; Guo-Xia Tong; Spiros Manolidis; Lanny G Close; Adel M Assaad; Gloria H Su
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

7.  Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.

Authors:  A Abramyuk; S Appold; K Zöphel; M Baumann; N Abolmaali
Journal:  Strahlenther Onkol       Date:  2013-01-19       Impact factor: 3.621

8.  Inhibition of Mammalian target of rapamycin by rapamycin causes the regression of carcinogen-induced skin tumor lesions.

Authors:  Panomwat Amornphimoltham; Kantima Leelahavanichkul; Alfredo Molinolo; Vyomesh Patel; J Silvio Gutkind
Journal:  Clin Cancer Res       Date:  2008-12-10       Impact factor: 12.531

9.  Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression.

Authors:  Christoph Bergmann; Laura Strauss; Eva Wieckowski; Malgorzata Czystowska; Andreas Albers; Yun Wang; Reinhard Zeidler; Stephan Lang; Theresa L Whiteside
Journal:  Head Neck       Date:  2009-03       Impact factor: 3.147

10.  A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis.

Authors:  Kantima Leelahavanichkul; Panomwat Amornphimoltham; Alfredo A Molinolo; John R Basile; Sittichai Koontongkaew; J Silvio Gutkind
Journal:  Mol Oncol       Date:  2013-10-12       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.